Cytokinetics, Incorporated Earning Date (CYTK)

USA |NASDAQ |USD

CYTK Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 $-1.00 - $-0.86
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 $3.95M - $2.84M

Cytokinetics, Incorporated's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

CYTK Earnings Date & History Chart

CYTK Earnings & Revenue Forecast

CYTK Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 11 $-1.00 $-1.12 $-0.83
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 12 $-4.00 $-4.56 $-2.53
Dec 2023 11 $-4.07 $-5.33 $-1.73

CYTK Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $-1.00 $-0.94 $-0.89
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-4.02 $-3.28 $-3.54
Dec 2023 1 / 0 $-4.08 $-3.67 $-3.42

CYTK Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 10 $3.95M $0.00 $6.25M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 13 $24.61M $0.00 $65.00M
Dec 2023 12 $85.02M $0.00 $289.00M

CYTK Earnings Date & Revenue History

CYTK Earnings History

|
Show More
Show More

CYTK Revenue History

|
Show More
Show More

Cytokinetics, Incorporated Next Earnings Date & Report

CYTK Next Earnings Date & Report Preview: Jun 2022 (FQ)

CYTK's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Cytokinetics, Incorporated's next quarterly earnings is $-1.00, with a low EPS estimation of $-1.12, and a high estimation of $-0.83.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.00, the last 2 month trend is $-0.94, and the 3 month trend is $-0.89.

Based on analysts, the average revenue estimation is $3.95M, with a low revenue estimation of $0.00, and a high estimation of $6.25M.

Cytokinetics, Incorporated Previous Earnings Dates & Reports

CYTK Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Cytokinetics, Incorporated's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

CYTK Previous Earnings Date & Report Recap: Dec 2021 (FY)

Cytokinetics, Incorporated's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

CYTK's earnings per share (EPS) was $-2.83, beating the consensus analysts forecast of $-3.27 by -13.46% , and lower than the previous year's EPS (Dec 2020) by 40.80%.

Revenues were $70.43M, better than the forecast of $21.28M by 230.96%, and up by 26.15% from previous year's revenue.

The company reported a net income of $-215.31M.

Cytokinetics, Incorporated reported a free cash flow of $-191.39M for its fiscal year, compared to $-2.11M a year ago.

The company ended the fiscal year with $269.93M in total debt, an increase of 94.90% compared to the previous year.